Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Shuttle Pharmaceuticals(SHPH) the EBIT is -2.217 M (+24.89%);the EPS is -4.28 (+94.37%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B24.89%
----
----
EPS
-4.277994.37%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf